212 related articles for article (PubMed ID: 18033029)
1. [New approaches for the treatment of metabolic myopathies].
Laforêt P; Nicolino M; Eymard B
Rev Neurol (Paris); 2007 Oct; 163(10):930-5. PubMed ID: 18033029
[TBL] [Abstract][Full Text] [Related]
2. Metabolic myopathies: the challenge of new treatments.
Angelini C; Semplicini C
Curr Opin Pharmacol; 2010 Jun; 10(3):338-45. PubMed ID: 20356791
[TBL] [Abstract][Full Text] [Related]
3. No effect of bezafibrate in patients with CPTII and VLCAD deficiencies.
Ørngreen MC; Vissing J; Laforét P
J Inherit Metab Dis; 2015 Mar; 38(2):373-4. PubMed ID: 25331908
[No Abstract] [Full Text] [Related]
4. Therapeutic options in other metabolic myopathies.
Vorgerd M
Neurotherapeutics; 2008 Oct; 5(4):579-82. PubMed ID: 19019309
[TBL] [Abstract][Full Text] [Related]
5. [Mitochondrial and metabolic myopathies].
de Wazières B; Dupond JL
Rev Prat; 2001 Feb; 51(3):256-61. PubMed ID: 11265421
[TBL] [Abstract][Full Text] [Related]
6. Metabolic myopathies: a clinical approach; part II.
Darras BT; Friedman NR
Pediatr Neurol; 2000 Mar; 22(3):171-81. PubMed ID: 10734246
[TBL] [Abstract][Full Text] [Related]
7. [Metabolic myopathies - an overview].
Lammens M; Schoser B
Pathologe; 2009 Sep; 30(5):370-8. PubMed ID: 19633854
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic myopathies].
Papazian Ó; Rivas-Chacón R
Rev Neurol; 2013 Sep; 57 Suppl 1():S65-73. PubMed ID: 23897158
[TBL] [Abstract][Full Text] [Related]
9. Metabolic myopathies: evaluation by graded exercise testing.
Elliot DL; Buist NR; Goldberg L; Kennaway NG; Powell BR; Kuehl KS
Medicine (Baltimore); 1989 May; 68(3):163-72. PubMed ID: 2716515
[TBL] [Abstract][Full Text] [Related]
10. Hereditary metabolic cardiomyopathies.
Servidei S; Bertini E; DiMauro S
Adv Pediatr; 1994; 41():1-32. PubMed ID: 7992680
[No Abstract] [Full Text] [Related]
11. Metabolic Myopathies.
Tarnopolsky MA
Continuum (Minneap Minn); 2022 Dec; 28(6):1752-1777. PubMed ID: 36537979
[TBL] [Abstract][Full Text] [Related]
12. Metabolic myopathies.
Bosch EP; Munsat TL
Med Clin North Am; 1979 Jul; 63(4):759-82. PubMed ID: 157414
[No Abstract] [Full Text] [Related]
13. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency.
Bonnefont JP; Bastin J; Laforêt P; Aubey F; Mogenet A; Romano S; Ricquier D; Gobin-Limballe S; Vassault A; Behin A; Eymard B; Bresson JL; Djouadi F
Clin Pharmacol Ther; 2010 Jul; 88(1):101-8. PubMed ID: 20505667
[TBL] [Abstract][Full Text] [Related]
14. Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features.
Lehmann D; Motlagh L; Robaa D; Zierz S
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054946
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of metabolic myopathies].
Reichmann H
Nervenarzt; 1993 Oct; 64(10):627-32. PubMed ID: 8232675
[TBL] [Abstract][Full Text] [Related]
16. Myopathies due to enzyme deficiencies.
Cornelio F; Di Donato S
J Neurol; 1985; 232(6):329-40. PubMed ID: 2934518
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Myopathies.
Tarnopolsky MA
Continuum (Minneap Minn); 2016 Dec; 22(6, Muscle and Neuromuscular Junction Disorders):1829-1851. PubMed ID: 27922496
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of metabolic myopathies.
Bhai SF; Vissing J
Muscle Nerve; 2023 Sep; 68(3):250-256. PubMed ID: 37226557
[TBL] [Abstract][Full Text] [Related]
19. Neonatal metabolic myopathies.
Tein I
Semin Perinatol; 1999 Apr; 23(2):125-51. PubMed ID: 10331465
[TBL] [Abstract][Full Text] [Related]
20. Spectrum of metabolic myopathies.
Angelini C
Biochim Biophys Acta; 2015 Apr; 1852(4):615-21. PubMed ID: 24997454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
